Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.100
+0.050 (4.76%)
At close: Dec 20, 2024, 4:00 PM
1.110
+0.010 (0.91%)
After-hours: Dec 20, 2024, 5:11 PM EST
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $93.53 million as of December 20, 2024. Its market cap has decreased by -32.91% in one year.
Market Cap
93.53M
Enterprise Value
-49.98M
1-Year Change
-32.91%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $93.53M, a decrease of -91.10%. That is a compound annual growth rate of -49.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 93.53M | -52.92% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 91.58M |
| Zentek | 91.34M |
| Tiziana Life Sciences | 90.76M |
| Nuvectis Pharma | 90.62M |
| bluebird bio | 89.74M |
| Adagene | 88.98M |
| HilleVax | 88.27M |
| Fractyl Health | 87.54M |